Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions.

Pharmaceuticals (Basel) · 2024 · PMC11279454 · PMID 39065751

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a trend towards significanceno p-value reported

2%), although the cumulative risk of an SMP was only a trend towards significance.

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.